Plan B and the FDA: The Saga Continues
Oh Sweet Mystery of [the FDA's decision on] Plan B:
WASHINGTON - A top federal health official rejected a Democratic accusation Thursday that politics were getting in the way of a decision on whether to permit sales of the morning-after contraceptive pill without a prescription.
Andrew Von Eschenbach, the Food and Drug Administration's acting director, tried to reassure House members that the decision would be based on science, not politics. "That process will be carried out in the appropriate fashion," he said.
Von Eschenbach said he couldn't say when the agency might rule.
[Maybe if the FDA hired a palm reader the agency would have a better grasp on the timeline.]
If not for the real life negative consequences of capriciously denying OTC availability for Plan B, Mr. Von Eschenbach's comments would be quite amusing.